VanEck Pharmaceutical ETF (PPH) — ()
Key Metrics
News
Should You Invest in the VanEck Pharmaceutical ETF (PPH)?
Published: by:
Sentiment: Neutral ()
The VanEck Pharmaceutical ETF (PPH) was launched on 12/20/2011, and is a passively managed exchange traded fund designed to offer broad exposure to the Healthcare - Pharma segment of the …
Read More
ETFs on the Move Post U.S.-China Trade Deal
Published: by:
Sentiment: Positive ()
Let's delve into the ETF world following the 90-day U.S.-China trade deal.
Read More
A Look at Pharma ETFs After Strong Q1 Earnings
Published: by:
Sentiment: Positive ()
Many pharma bigwigs reported solid results, with some beating on earnings or revenues or both.
Read More
PPH: Will Overcome Tariffs, But Competitor Funds Look Stronger
Published: by:
Sentiment: Neutral ()
VanEck Pharmaceutical ETF holds a mixed outlook due to high fees and tariff risks, warranting a hold rating despite strong top holdings. PPH's top holdings like Eli Lilly and Johnson …
Read More
About VanEck Pharmaceutical ETF PPH
The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The index includes common stocks and depositary receipts of U.S. exchange-listed companies in the pharmaceutical industry. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.